Form 4: Edgewise Therapeutics CMO Joanne M. Donovan Sells Shares

Joanne M. Donovan, CMO of Edgewise Therapeutics, sold 7,162 shares of common stock at an average price of $28.2886 on September 20, 2024.

Summary

• On September 20, 2024, Joanne M. Donovan, the Chief Medical Officer (CMO) of Edgewise Therapeutics, Inc. (EWTX), sold 7,162 shares of the company's common stock.
• The shares were sold at an average price of $28.2886 per share.
• The sale was executed on the same day as the transaction date.
• Following the transaction, Donovan directly owns 14,538 shares of Edgewise Therapeutics common stock.
• This includes 1,803 shares purchased on May 15, 2024, through the company's Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock sale by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company executives, which can be of interest to investors.

Stakeholder Impact

• The sale of shares by a company executive may be perceived differently by stakeholders.
• Some may view it as a lack of confidence in the company's future prospects, while others may see it as a personal financial decision.

Key Dates